Omeros (OMER) EBT Margin Growth (3y) (2013 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 79,334.00 |
| Jun 30, 2021 | 189,681.00 |
| Mar 31, 2021 | 168,324.00 |
| Dec 31, 2020 | -70,187.00 |
| Sep 30, 2020 | -14,093.00 |
| Jun 30, 2020 | -16,328.00 |
| Mar 31, 2020 | -13.00 |
| Dec 31, 2019 | -22,392.00 |
| Sep 30, 2019 | 7,041.00 |
| Jun 30, 2019 | 7,223.00 |
| Mar 31, 2019 | 16,667.00 |
| Dec 31, 2018 | 17,508.00 |
| Sep 30, 2018 | -25,005.00 |
| Jun 30, 2018 | -154,168.00 |
| Mar 31, 2018 | 294,625.00 |
| Dec 31, 2017 | 1.16 Mn |
| Sep 30, 2017 | 840,890.00 |
| Jun 30, 2017 | 4.03 Mn |
| Mar 31, 2017 | 1.62 Mn |
| Dec 31, 2016 | 812,817.00 |
| Sep 30, 2016 | 702,956.00 |
| Jun 30, 2016 | 969,148.00 |
| Mar 31, 2016 | 68,740.00 |
| Dec 31, 2015 | 21,631.00 |
| Sep 30, 2015 | 32,917.00 |
| Jun 30, 2015 | 3,912.00 |
| Mar 31, 2015 | -429,599.00 |
| Dec 31, 2014 | -1.08 Mn |
| Sep 30, 2014 | -776,822.00 |
| Jun 30, 2014 | -3.99 Mn |
| Mar 31, 2014 | -1.58 Mn |
| Dec 31, 2013 | -733,250.00 |
| Sep 30, 2013 | -410,628.00 |
| Jun 30, 2013 | -820,520.00 |